Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans

Philip Rosenstock1,2, Rüdiger Horstkorte3, Vinayaga Srinivasan Gnanapragassam3

  • 1Institute for Physiological Chemistry, Martin Luther University Halle-Wittenberg, Hollystraße 1, 06114, Halle (Saale), Germany. philip.rosenstock@uk-halle.de.

Immunologic Research
|August 9, 2017
PubMed

Insights

Obesity is linked to reduced Siglec-7 expression on natural killer (NK) cells, potentially indicating immune dysfunction. Sialic acid levels differ between NK cell types, irrespective of weight.

Area of Science:

  • Immunology
  • Cell Biology
  • Metabolic Health

Background:

  • Obesity alters adipocytokine profiles, impacting innate immune cell function.
  • Natural killer (NK) cells are crucial for immune surveillance against tumors and viruses.
  • Sialic acid-binding immunoglobulin-like lectins (Siglecs) are inhibitory receptors on NK cells.

Purpose of the Study:

  • To compare the expression of Siglec-7, -9, and -10 on NK cells from normal weight and obese individuals.
  • To investigate the role of sialic acid on NK cell surface in relation to body weight.
  • To assess Siglec expression on NK cell lines.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) were isolated from normal weight (BMI < 25 kg/m²) and obese (BMI > 30 kg/m²) donors.
  • Flow cytometry was used to analyze Siglec expression on NK cell subsets (CD56bright and CD56dim).
  • Fluorescently labeled lectins determined the amount of sialic acid on NK cells.

Main Results:

  • No significant differences in immune cell percentages were observed between groups.
  • Obese subjects showed reduced Siglec-7 expression on CD56bright NK cells compared to normal weight individuals.
  • CD56bright NK cells exhibited higher surface sialic acid levels than CD56dim NK cells, independent of BMI.

Conclusions:

  • Reduced Siglec-7 expression on CD56bright NK cells in obesity may signify impaired function.
  • Siglec-7, -9, and -10 are not expressed on NK cell lines NK-92 and NKL.
  • Sialic acid distribution on NK cell subsets is distinct and weight-independent.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
247
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
322
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K